Titan Pharmaceuticals
TTNP
#11013
Rank
HK$48.12 M
Marketcap
HK$36.18
Share price
-3.76%
Change (1 day)
17.09%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.45. In 2023 the company made an earnings per share (EPS) of -HK$58.15 an increase over its 2022 EPS that were of -HK$119.20.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$58.15-51.22%
2022-HK$119.20-15.61%
2021-HK$141.25-81.37%
2020-HK$758.04-77.52%
2019-HK$3,373-56.32%
2018-HK$7,722-59.51%
2017-HK$19,073-371.81%
2016HK$7,017-144.35%
2015-HK$15,820300%
2014-HK$3,955-121.54%
2013HK$18,363-151.38%
2012-HK$35,736-11.54%
2011-HK$40,398188.89%
2010-HK$13,984-10%
2009-HK$15,538
2007-HK$63,704-2.38%
2006-HK$65,258-39.13%
2005-HK$107,209-16.87%
2004-HK$128,962-22.43%
2003-HK$166,2524.9%
2002-HK$158,48361.9%
2001-HK$97,887-13.7%
2000-HK$113,42465.01%
1999-HK$68,739-35.87%
1998-HK$107,191-1824.71%
1997HK$6,215-102.4%
1996-HK$259,478

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.54-298.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$52.26-251.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-HK$36.33 5.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$5.89-117.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.80-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.14-0.91%๐Ÿ‡บ๐Ÿ‡ธ USA